DataVault AI has entered into an exclusive license agreement with Wellgistics Health for utilizing blockchain-enabled smart contracts in pharmaceutical distribution.
The agreement aims to digitize the tracking of prescription drugs to ensure safe and efficient dispensing.
Wellgistics Health is set to leverage AI technologies to disrupt the US prescription drug industry with a focus on cost reduction and improved patient outcomes.
Exclusive License Agreement
DataVault AI grants Wellgistics Health exclusive access to patents for pharmaceutical distribution.
Web 3.0 Technology
Utilizing Web 3.0 smart contracts to optimize prescription drug tracking and dispension.
Market Disruption
Aiming to disrupt the $634 billion US prescription drug industry with innovative technology.
Cost Efficiency
Reducing costs for payers and improving outcomes for patients through digitization and automation.
- The collaboration between DataVault AI and Wellgistics Health is expected to streamline prescription drug distribution processes.
- Utilizing blockchain-enabled smart contracts can enhance transparency and efficiency in the pharmaceutical supply chain.
The partnership between DataVault AI and Wellgistics Health marks a significant step towards revolutionizing pharmaceutical distribution with cutting-edge technology and automation.